Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Outcomes with Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Relapsed/Refractory Follicular Lymphoma (FL) in the Post-Rituximab Era: A Comparative Analysis From the National Comprehensive Cancer Network (NCCN) Non-Hodgkin's Lymphoma (NHL) Outcomes Database Project,

Andrew M. Evens, DO, MSc, Ann Vanderplas, M.S., Ann LaCasce, MD, MSc, Allison Crosby, MS, Auayporn Nademanee, M.D., Mark S. Kaminski, MD, Gregory A. Abel, MD, MPH, Michael Millenson, MD, Myron S. Czuczman, MD, Maria A. Rodriguez, MD, Joyce Niland, PhD, Andrew D Zelenetz, MD, PhD, Leo I. Gordon, MD, FACP, Jonathan Friedberg, MD

Blood (2011) 118 (21): 4112.

https://doi.org/10.1182/blood.V118.21.4112.4112

Published: 2011

Journal Articles

Incidence, Method and Covariates of Central Nervous System (CNS) Prophylaxis for Diffuse Large B-Cell Lymphoma In the National Comprehensive Cancer Network (NCCN) Lymphoma Database

Anita Kumar, MD, Ann Vanderplas, Ann S. LaCasce, MD, MSc, Maria A. Rodriguez, MD, Allison L. Crosby, MS, Eva Lepisto, MSc, MA, Myron S. Czuczman, MD, Auayporn Nademanee, M.D., Joyce Niland, PhD, Leo I. Gordon, MD, FACP, Michael Millenson, MD, Andrew D. Zelenetz, MD, PhD, Jonathan W. Friedberg, MD, Gregory A. Abel, MD, MPH

Blood (2010) 116 (21): 1756.

https://doi.org/10.1182/blood.V116.21.1756.1756

Published: 2010

Journal Articles

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Amrita Krishnan, M.D., Joycelynne Palmer, PhD, Auayporn Nademanee, M.D., Andrew Raubitschek, MD, Dave Yamauchi, Neil Martin Kogut, MD, Laura Federico, Nicole Tsai, Stephen Forman, M.D.

Blood (2010) 116 (21): 32.

https://doi.org/10.1182/blood.V116.21.32.32

Published: 2010

Journal Articles

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

Mark Kirschbaum, MD, Anthony Selwyn Stein, M.D., Paul Frankel, Leslie Popplewell, M.D., Robert w Chen, Maria L Delioukina, MD, Ryotaro Nakamura, MD, David S. Snyder, MD, Cynthia Slape, Christopher Ruel, Joel Conrad, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 528.

https://doi.org/10.1182/blood.V116.21.528.528

Published: 2010

Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Mark Kirschbaum, MD, Leslie Popplewell, M.D., Maria L Delioukina, MD, Robert w Chen, Vinod Pullarkat, Paul Frankel, Joel Conrad, Joyce Hartshorn, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 3957.

https://doi.org/10.1182/blood.V116.21.3957.3957

Published: 2010

Journal Articles

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Ari M. Vander Walde, M.D., M.P.H., Can-Lan Sun, Ph.D., Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Neal Kogut, M.D., Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 933.

https://doi.org/10.1182/blood.V116.21.933.933

Published: 2010

Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 902.

https://doi.org/10.1182/blood.V116.21.902.902

Published: 2010

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Cell Depleted.

Robert Chow, MD, Patrick Tan, M.D., Tang-Her Jaing, M.D., Joseph Rosenthal, M.D., Auayporn Nademanee, M.D., Chatchada Karanes, M.D., Michael Graham, M.D., Gretchen Eames, M.D., Lee Lee Chan, M.D., Brian Wang, M.S., Tiffany Chow, Tina Wu, Ah Moy Tan, M.D., Poh-Lin Tan, M.D., Hai-Peng Lin, M.D., David Gjertson, Ph.D., Lawrence Petz, M.D.

Blood (2006) 108 (11): 5231.

https://doi.org/10.1182/blood.V108.11.5231.5231

Published: 2006

Journal Articles

Concordance with National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines (CPGs): A Quality of Care Tool for Newly Diagnosed Patients (pts) with Mantle Cell Lymphoma (MCL).

Maria Alma Rodriguez, MD, Anna Ter Veer, MS, Auayporn Nademanee, M.D., Joyce Niland, Ph.D., Eva Lepisto, MS, Michelle Kho, MSc, Ann LaCasce, M.D., Jane Carrie Weeks, M.D., Myron Czuczman, M.D., Michael Millenson, M.D., Jonathan Friedberg, M.D., Andrew D. Zelenetz, M.D.

Blood (2006) 108 (11): 3328.

https://doi.org/10.1182/blood.V108.11.3328.3328

Published: 2006

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells.

Joseph Rosenthal, MD, Tang-Her Jaing, M.D., Auayporn Nademanee, M.D., Chatchada Karanes, M.D., Michael Graham, M.D., Lee Lee Chan, M.D., Gretchen Eames, M.D., Ah Moy Tan, M.D., Poh-Lin Tan, M.D., Brian Wang, M.S., Peggy Tseng, Tiffany Chow, Tina Wu, Hai-Peng Lin, M.D., David Gjertson, PhD, Lawrence Petz, M.D., Patrick Tan, M.D., Robert Chow, M.D.

Blood (2006) 108 (11): 3151.

https://doi.org/10.1182/blood.V108.11.3151.3151

Published: 2006

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) for Malignancies Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Blood Cell Depleted.

Lawrence Petz, MD, Auayporn Nademanee, M.D., Joseph Rosenthal, M.D., Michael Graham, M.D., Gretchen Eames, M.D., Chatchada Karanes, M.D., Lee Lee Chan, M.D., Ah Moy Tan, M.D., Poh-Lin Tan, M.D., Brian Wang, M.S., Peggy Tseng, Tiffany Chow, Tina Wu, Tang-Her Jaing, M.D., David Gjertson, PhD, Patrick Tan, M.D., Robert Chow, MD

Blood (2006) 108 (11): 5418.

https://doi.org/10.1182/blood.V108.11.5418.5418

Published: 2006

Journal Articles

Post-That Washing Prior to Transplantation of Umbilical Cord Blood (UCB) That Were Depleted of Plasma but Not of Red Blood Cells.

Blood (2006) 108 (11): 5229.

https://doi.org/10.1182/blood.V108.11.5229.5229

Published: 2006

NARROW

Outcomes with Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Relapsed/Refractory Follicular Lymphoma (FL) in the Post-Rituximab Era: A Comparative Analysis From the National Comprehensive Cancer Network (NCCN) Non-Hodgkin's Lymphoma (NHL) Outcomes Database Project,

Incidence, Method and Covariates of Central Nervous System (CNS) Prophylaxis for Diffuse Large B-Cell Lymphoma In the National Comprehensive Cancer Network (NCCN) Lymphoma Database

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Cause-Specific Conditional Survival In 2603 Consecutive Patients Undergoing Autologous Hematopoietic Cell Transplantation (aHCT) Over a 20-Year Period

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Hematopoietic Stem Cell Transplantation (HSCT) Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Cell Depleted.

Concordance with National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines (CPGs): A Quality of Care Tool for Newly Diagnosed Patients (pts) with Mantle Cell Lymphoma (MCL).

Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells.

Hematopoietic Stem Cell Transplantation (HSCT) for Malignancies Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Blood Cell Depleted.

Post-That Washing Prior to Transplantation of Umbilical Cord Blood (UCB) That Were Depleted of Plasma but Not of Red Blood Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only